Molecular Signature Predicts Prognosis in Oral Cancer
Author Information
Author(s): Peng Chien-Hua, Liao Chun-Ta, Peng Shih-Chi, Chen Yin-Ju, Cheng Ann-Joy, Juang Jyh-Lyh, Tsai Chi-Ying, Chen Tse-Ching, Chuang Yung-Jen, Tang Chuan-Yi, Hsieh Wen-Ping, Yen Tzu-Chen
Primary Institution: Chang Gung Memorial Hospital and Chang Gung University
Hypothesis
The study investigates the genetic basis of variations in gene expression associated with poor prognosis in oral squamous cell carcinoma (OSCC).
Conclusion
The study identified a candidate molecular signature associated with poor prognosis in OSCC patients, which may help in selecting tailored therapeutic strategies.
Supporting Evidence
- Identified recurrent DNA amplifications in 112 OSCC specimens.
- Confirmed associations with increased incidence of extracapsular spread and poor survival.
- Validation panel of 295 cases supported the predictive value of 8q22.2∼24.3 amplification.
Takeaway
Researchers found specific genetic changes in oral cancer that can help predict how well patients will do, which could lead to better treatment plans.
Methodology
The study used Affymetrix SNP 6.0 and GeneChip Human Gene 1.0 ST arrays to analyze gene expression and copy number variations in OSCC specimens.
Potential Biases
Potential biases may arise from the selection of samples and the methods used for genetic analysis.
Limitations
The study's findings may not be generalizable without further validation in larger cohorts.
Participant Demographics
The study included 112 OSCC patients, primarily affected by oral risk factors such as tobacco and betel quid.
Statistical Information
P-Value
0.0246
Confidence Interval
(1.109, 5.245)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website